comparemela.com

Latest Breaking News On - George lemaitre - Page 7 : comparemela.com

LeMaitre Vascular inc (LMAT) Q4 2020 Earnings Call Transcript

LeMaitre Vascular inc (LMAT) Q4 2020 Earnings Call Transcript Motley Fool Transcribers © The Motley Fool Logo of jester cap with thought bubble. LeMaitre Vascular inc (NASDAQ: LMAT) Popular Searches Welcome to the LeMaitre Vascular Q4 2020 Financial Results Conference Call. [Operator Instructions] At this time, I would like to turn the call over to Mr. JJ Pellegrino, Chief Financial Officer of LeMaitre Vascular. Please go ahead, sir. This article is a transcript of this conference call produced for The Motley Fool. While we strive for our Foolish Best, there may be errors, omissions, or inaccuracies in this transcript. As with all our articles, The Motley Fool does not assume any responsibility for your use of this content, and we strongly encourage you to do your own research, including listening to the call yourself and reading the company s SEC filings. Please see our

LeMaitre Q4 2020 Financial Results

Press release content from Globe Newswire. The AP news staff was not involved in its creation. LeMaitre Q4 2020 Financial Results LeMaitre Vascular, Inc.February 25, 2021 GMT BURLINGTON, Mass., Feb. 25, 2021 (GLOBE NEWSWIRE) LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q4 2020 results and announced an $0.11/share quarterly dividend. Q4 2020 Results Op. income of $9.5mm, +94% Op. margin of 25% Earnings of $0.34 per diluted share, +51% EBITDA of $11.9mm, +84% ADVERTISEMENT The Company posted sales growth in the Americas (+35%), Asia/Pac (+12%) and Europe/Middle East/Africa (+9%). The three recent acquisitions (Artegraft, CardioCel and Eze-Sit) led growth in Q4 2020. By product, biologic grafts, valvulotomes and embolectomy catheters drove sales.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.